Follicular Contact Dermatitis Revisited: A Review Emphasizing Neomycin-Associated Follicular Contact Dermatitis

    January 2014 in “ World journal of clinical cases ”
    Philip R. Cohen
    TLDR Neomycin is a common cause of follicular contact dermatitis, which is treated by avoiding the allergen and using creams.
    The 2014 review titled "Follicular contact dermatitis revisited: A review emphasizing neomycin-associated follicular contact dermatitis" focused on follicular contact dermatitis, a condition characterized by individual papules with a central hair follicle, often resulting in hair loss and inflammation. The document highlighted neomycin, a common antibiotic found in topical creams and ointments, as a frequent cause of this dermatitis. The authors suggested that factors such as patient allergenicity, characteristics of the agent, the vehicle containing the agent, application of the agent, and external factors could influence the development of this condition. The primary treatment for follicular contact dermatitis is the withdrawal of the causative agent, with topical corticosteroids also used to promote resolution of the dermatitis. The authors emphasized the importance of recognizing the symptoms and avoiding products containing neomycin to prevent the condition.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 162 results

    Similar Research

    5 / 1000+ results
      Madarosis

      research Madarosis

      33 citations, November 2006 in “Survey of Ophthalmology”
      Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.
      Index

      research Index

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      The document is a detailed medical reference on skin and genetic disorders.
      Common Dermatologic Conditions

      research Common Dermatologic Conditions

      14 citations, April 2014 in “Medical Clinics of North America”
      The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.